Whiting D A. Ligans and neolignans[J]. Nat Prod Rep, 1985,2 (3) :191.
[2]
Whiting D A. Lignans, neolignans, and related compounds[J]. Nat Prod Rep, 1987,4(5) :499.
[3]
Robert S Ward. Lignans, neolignans and related compounds[J]. Nat Prod Rep, 1997,14(1) :43.
[4]
Robert S Ward. Lignans, neolignans, and related compounds [J]. Nat Prod Rep, 1995,12(2) :183.
[5]
Robert S Ward. Lignaans neolignans, and related compounds[J]. Nat Prod Rep, 1993,10(1) :1.
[6]
Whiting D A. Lignans, neolignans, and related compounds[J]. Nat Prod Rep, 1990,7(4) :349.
[7]
Robert S Ward. Lignans, neolignans and related compounds[J]. Nat Prod Rep, 1999,16(1) :75.
[8]
MacRae W D, Towers G H N. Biological and activity of lignans [J]. Phytochemistry, 1984,23(6) :1207.
[9]
Ros J L, Giner R M, Prieto J M. New approaches on the bioactivity of lignans [M]. Studies in Natural Products Chemistry, 26 (Part G), Amsterdam: Ed. Atta-Ur-Rahman, Elsevier Science B. V, 2002:183.
[10]
Lee K H, Xiao Z Y. Lignans in treatment of cancer and other diseases[J]. Phytochemistry Bev, 2003,2(3) :341.
[11]
Imbert T F. Discovery of podophyllotoxins[J]. Biochimie, 1998, 80(3) :207.
[12]
Cow C, Leung C, Charlton J L. Antiviral activity of arylna-phthalene and aryldihydronaphthalene lignans[J]. Can J Chem, 2000, 78(5) :553.
[13]
Lee S, Ban H S, Kim Y P, et al. Lignans from Acanthopanax chlisanensis having an inhibitory activity on prostaglandin E2 production[J]. Phytother Res, 2005,19(2) :103.
[14]
Susplugas S, Hung N V, Bignon J, et al. Cytotoxic arylnaphthale-ne lignans from a vietnamese acanthaceae, Justicia patentiflora [J]. J Nat Prod, 2005,68(5):734.
[15]
Innocenti G, Puricelli L, Piacente S, et al. Patavine, a new arylnaphthalene lignan glycoside from shoot cultures of Hoplophyllum petavinum[J]. Chem Phar Bull, 2002,50(6) :844.
[16]
Navarro E, Alonso S J, Trujillo J, et al. Elenoside, a new cytotoxic drug, with cardiac and extracardiac activity[J]. Biol Pharm Bull, 2002,25(8) :1013.
[17]
Navarro E, Alonso S J, Trujillo J, et al. General behavior, toxicity, and cytotoxic activity of elenoside, a lignan from Justicia hyssopifolia[J]. J Nat Prod, 2001,64(1) :134.
[18]
Muta Y, Oyama S, Umezawa T, et al. Inhibitory effects of lignaris on the activity of human matrix metalloproteinase 7 (matrilysin) [J]. J Agric Food Chem, 2004,52(19) :5888.
[19]
Ma C J, Sung S H, Kim Y C. Neuroprotective dibenzylbutyrolaetone lignans of Torreya nucifera[J]. Planta Med, 2001,67:470.
[20]
Gordaliza M, Castro M A, Miguel J M, et al. Antitumor properties of podophyllotoxin and related compounds [J]. Curr Pharm Des, 2000,6(29):1811.
[21]
Kim S H, Jang Y P, Sung S H, et al. Hepatoprotective dibenzylbutyrolactone lignans of torreya nucifera against CCl4-induced toxicity in primary cultured rat hepatocytes [J]. Biol Pharm Bull, 2003,26(8):1202.
[22]
Cho M K, Janga Y P, Kim Y C, et al. Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits MAP kinases and AP-1 activation via potent MKK inhibition: the role in TNF-a inhibition[J]. Int Immunopharmacol, 2004,4(10) :1419.
[23]
Silva R, Souza G H, Silva A, et al. Synthesis and biological activity evaluation of liglaan lactones derived from (-)-cubebin [J]. Bioorg Med Chem Lett, 2005,15(4):1033.
[24]
Nascimento M S J, Pedrol M, Cerqueiral F, et al. Effect of natural 2, 5-diaryl-3, 4-dimethyltetrahydrofuran lignans on complement activation, lymphocyte proliferation, and growth of tumor cell Lines[J]. Pharmaceutical Biology, 2004,42(6):449.
[25]
Schmidt T J, JφrgHelmann. Tetrahydrofuran lignans from Illicium floridanum and their activity in a luminol enhanced chemiluminescence assay[J]. Planta Med, 2000,66:749.
[26]
Nguyen N T, Banskota A H, Tezuka Y. Hepatoprotective effect of taxiresinol and 7\\'-hydroxylariciresinol on d-galactosamine and lipolysaccharide-induced liver injury in mice [J]. Planta Med, 2004,70 : 29.
[27]
Tang S, Bremner P, Kortenkamp A, et al. Biflavonoids with cytotoxic and antibacterial activity from ochna macrocaly[J]. Planta Med, 2003,69:247.
[28]
Park B Y, Min B S, Kwon O K, et al. Increase of caspase-3 activity by lignans from Machilus thunbergii in HL-60 cells[J]. Biol Pharm Bull, 2004,27(8) :1305.
[29]
Filleur F, Bail J C Le, Duroux J L, et al. Antiproliferative, antiaromatase, anti-17b-HSD and a ntioxidant activities of liglnans isolated from Myristica argentea[J]. Planta Med, 2001,67:700.
[30]
Kim S R, Lee M K, Koo K A, et al. Dibenzocyclooctadiene lignans from Schisandra chinensis protect primary cultures of rat cortical cells from glutamate-induced toxicity [J]. J Neurosci Res, 2004,76(3) :397.
[31]
Pan Q R, Lu Q H, Zhang K, et al. Dibenzocyclooctadiene lingnaris: a class of novel inhibitors of P-glycoprotein [J]. Cancer Chemother Pharmacol, 2006,58(1):99.
[32]
Choi Y W, Takamatsu S, Khan S I, et al. Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene liglaans [J]. J Nat Prod. 2006,69(3) :356.
[33]
Iwata H, Tezuka Y, Kadota S, et al. Identification and characterization of potent CYP3A4 inhibitors in drug metabolism and disposition Schisandra fruit extract [ J ]. Drug Metab Dispos, 2004, 32(12) :1351.
[34]
Meragelman K M, McKee T C, Boyd M R, et al. 10-demethoxystegane, a new lign-an from Steganotaenia araliacea [J]. J Nat Prod, 2001,64(11):1480.
[35]
Pessini G L, Dfilho B P, Nakamura C V, et al. Antibacterial activity of extracts and neolignans from Piper regnellii (Miq.) C. DC. var. pallescens ( C. DC. ) Yunck [J]. Mere Inst Oswaldo Cruz, Rio de Janeiro, 2003,98(8) :1115.
[36]
Pessini G L, Filhob B P D, Nakamura C V, et al. Antifungal activity of the extracts and neolignans from Piper regnellii( Miq. ) C. De. var. pallescens ( C. De. ) Yunck [ J ]. J Braz Chem Soc, 2005,16(6A) :1130.
[37]
Frexia B, Vila R, Estenban A, et al. Antifungal principals from Piper fulvescens[J]. Planta Med, 2001,67:873.
[38]
Ahn B T, Lee S, Lee S B, et al. Low-density lipoprotein-antioxidant constituents of Saururus chinensis[J]. J Nat Prod, 2001,64 (12) : 1562.
